These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 10319757)

  • 1. Assessment of myocardial viability using 123I-labeled iodophenylpentadecanoic acid at sustained low flow or after acute infarction and reperfusion.
    Yang JY; Ruiz M; Calnon DA; Watson DD; Beller GA; Glover DK
    J Nucl Med; 1999 May; 40(5):821-8. PubMed ID: 10319757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability.
    Sansoy V; Glover DK; Watson DD; Ruiz M; Smith WH; Simanis JP; Beller GA
    Circulation; 1995 Aug; 92(4):994-1004. PubMed ID: 7641384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc-tetrofosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion.
    Glover DK; Ruiz M; Koplan BA; Watson DD; Beller GA
    J Nucl Med; 1999 Jan; 40(1):142-9. PubMed ID: 9935070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion.
    Beller GA; Glover DK; Edwards NC; Ruiz M; Simanis JP; Watson DD
    Circulation; 1993 Jun; 87(6):2033-42. PubMed ID: 8504518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of myocardial p-(123)I-iodophenylpentadecanoic acid retention with (18)F-FDG accumulation during experimental low-flow ischemia.
    Shi CQ; Young LH; Daher E; DiBella EV; Liu YH; Heller EN; Zoghbi S; Wackers FJ; Soufer R; Sinusas AJ
    J Nucl Med; 2002 Mar; 43(3):421-31. PubMed ID: 11884504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodophenylpentadecanoic acid-myocardial blood flow relationship during maximal exercise with coronary occlusion.
    Caldwell JH; Martin GV; Link JM; Krohn KA; Bassingthwaighte JB
    J Nucl Med; 1990 Jan; 31(1):99-105. PubMed ID: 2295946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of myocardial viability with iodine-123-BMIPP in a canine model.
    Nohara R; Okuda K; Ogino M; Hosokawa R; Tamaki N; Konishi J; Fujibayashi Y; Yonekura Y; Fujita M; Sasayama S
    J Nucl Med; 1996 Aug; 37(8):1403-7. PubMed ID: 8708784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early assessment of tissue viability with radioiodinated heptadecanoic acid in reperfused canine myocardium: comparison with thallium-201.
    Chappuis F; Meier B; Belenger J; Bläuenstein P; Lerch R
    Am Heart J; 1990 Apr; 119(4):833-41. PubMed ID: 1690945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-pyrophosphate uptake as an indicator of myocardial injury without infarct.
    Okuda K; Nohara R; Fujita M; Tamaki N; Konishi J; Sasayama S
    J Nucl Med; 1994 Aug; 35(8):1366-70. PubMed ID: 8046495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viability after myocardial infarction: can it be assessed within five minutes by low-dose dynamic iodine-123-iodophenylpentadecanoic acid imaging with a multicrystal gamma camera?
    Murray GL; Schad N; Bush AJ
    Angiology; 1997 Apr; 48(4):309-19. PubMed ID: 9112879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial viability assessment with dynamic low-dose iodine-123-iodophenylpentadecanoic acid metabolic imaging: comparison with myocardial biopsy and reinjection SPECT thallium after myocardial infarction.
    Murray GL; Schad NC; Magill HL; Vander Zwaag R
    J Nucl Med; 1994 Apr; 35(4 Suppl):43S-48S. PubMed ID: 8151413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction.
    Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK
    J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow.
    Vanzetto G; Calnon DA; Ruiz M; Watson DD; Pasqualini R; Beller GA; Glover DK
    Circulation; 1997 Oct; 96(7):2325-31. PubMed ID: 9337207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.
    Johnson G; Okada CC; Hocherman SD; Liu Z; Hart C; Khaw BA; Okada RD
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):319-28. PubMed ID: 16237571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolism of 15-p-[123I]-iodophenylpentadecanoic acid in a surgically induced canine model of regional ischemia.
    Hudon MP; Lyster DM; Jamieson WR; Qayumi AK; Sartori C; Dougan H
    Eur J Nucl Med; 1990; 16(4-6):199-204. PubMed ID: 2351167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-N-NOET myocardial uptake reflects myocardial blood flow and not viability in dogs with reperfused acute myocardial infarction.
    Vanzetto G; Glover DK; Ruiz M; Calnon DA; Pasqualini R; Watson DD; Beller GA
    Circulation; 2000 May; 101(20):2424-30. PubMed ID: 10821821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting and nonfasting iodine-123-idophenylpentadecanoic acid myocardial SPECT imaging in coronary artery disease.
    Heller GV; Iskandrian AE; Orlandi C; Ahlberg AW; Heo J; Mann A; White MP; Gagnon A; Taillefer R
    J Nucl Med; 1998 Dec; 39(12):2019-22. PubMed ID: 9867134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.
    Okada DR; Johnson G; Liu Z; Hocherman SD; Khaw BA; Okada RD
    J Nucl Med; 2004 Apr; 45(4):655-64. PubMed ID: 15073263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I-iodophenylpentadecanoic acid.
    Verani MS; Taillefer R; Iskandrian AE; Mahmarian JJ; He ZX; Orlandi C
    J Nucl Med; 2000 Aug; 41(8):1299-307. PubMed ID: 10945518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myocardial scintigraphy with iodine 123-labeled fatty acids].
    Dudczak R
    Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.